CCB: calcium channel blockers; COVID-19: coronavirus disease 2019
: Potential substantially increased exposure of the medications; these
drugs should not be prescribed together.
: Potential moderately increased exposure of the medications; dosage
adjustment or close monitoring may be required.
: Potential mildly increased exposure of the medications; the
interactions are weak
-: No significant effects
Data about drug-drug interactions presented in this table were adopted
from the work by Liverpool Drug Interactions Group which could be found
at the following website:
https://www.covid19-druginteractions.org63
Table 2. Pharmacokinetics of medications for atrial
fibrillation and COVID-19.
COVID-19: coronavirus disease 2019